MIR7155: A Potential Drug Target and Biomarker for Cancer (G102466815)
MIR7155: A Potential Drug Target and Biomarker for Cancer
MIR7155 (hsa-miR-7155-5p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and recent studies have shed light on its potential role in the development and progression of these diseases.
MIR7155 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells throughout the body and is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.
One of the key features of MIR7155 is its unique structure. It is a double-stranded RNA molecule that has a length of approximately 200 nucleotides. The molecule has a stem-loop structure at its core and a 5' end that is composed of a single nucleotide. The 3' end of the molecule has a poly(A) tail, which is a common structure seen in miRNAs.
MIR7155 has been shown to play a role in the regulation of cellular processes in various organisms, including humans. For example, studies have shown that MIR7155 is involved in the regulation of cell growth, apoptosis, and inflammation.
In addition to its role in cellular processes, MIR7155 has also been shown to be involved in the regulation of gene expression. Studies have shown that MIR7155 can interact with various protein molecules and that it can modulate the activity of these proteins. This suggests that MIR7155 may be a key regulator of cellular processes and that it may play a role in the development and progression of various diseases.
One of the potential benefits of targeting MIR7155 is its potential as a drug target. Studies have shown that MIR7155 is highly expressed in various tissues and that it is involved in the regulation of cellular processes that are important for the development and progression of cancer. Additionally, MIR7155 has been shown to interact with various proteins that are involved in the development and progression of cancer, including the transcription factor E2F1. This suggests that targeting MIR7155 may be a promising strategy for the development of new cancer therapies.
Another potential benefit of targeting MIR7155 is its potential as a biomarker. Studies have shown that MIR7155 is expressed in various tissues and that it is involved in the regulation of cellular processes that are important for the development and progression of cancer. Additionally, MIR7155 has been shown to have unique expression patterns in various tissues, which may make it an attractive biomarker for the diagnosis and prognosis of cancer.
In conclusion, MIR7155 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and recent studies have shed light on its potential role in the development and progression of these diseases. Further research is needed to fully understand the role of MIR7155 in the regulation of cellular processes and its potential as a drug target and biomarker.
Protein Name: MicroRNA 7155
The "MIR7155 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7155 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934
